Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription 02.06.2025 8 Anticancer Res 5 BMC Cancer 2 Cancer Lett 2 Clin Cancer Res 6 Dis Colon Rectum 1 Eur J Cancer 6 Eur J Surg Oncol 2 Int J Cancer 1 Int J Colorectal Dis 1 J Natl Cancer Inst 6 J Surg Oncol 2 Oncogene 2 Oncology 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. MINAMI S, Miyoshi N, Fujino S, Yasui M, et al
   Role of the Circadian Clock Gene DEC1 in Chemosensitivity and Apoptosis in Colorectal Cancer.
   Anticancer Res. 2025;45:2309-2328.
   PubMed         Abstract available
   
   
2. YU X, Tsunedomi R, Hazama S, Nakagami Y, et al
   Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis.
   Anticancer Res. 2025;45:2385-2399.
   PubMed         Abstract available
   
   
3. ANDO Y, Orito H, Mizuno T, Katsuno H, et al
   Effect of a Biweekly Dosing Schedule on Severe Neutropenia Induced by Trifluridine/Tipiracil in Colorectal Cancer.
   Anticancer Res. 2025;45:2587-2594.
   PubMed         Abstract available
   
   
4. ESKELINEN M, Selander T, Guimaraes DP, Kaarniranta K, et al
   Four Different Artificial Intelligence Models Versus Logistic Regression to Enhance the Diagnostic Accuracy of Fecal Immunochemical Test in the Detection of Colorectal Carcinoma in a Screening Setting.
   Anticancer Res. 2025;45:2477-2491.
   PubMed         Abstract available
   
   
5. KODAMA H, Yamaguchi T, Kameishi S, Kadono T, et al
   Tumor Budding Grade and T Stage as Recurrence Predictors of High-risk Stage II Colorectal Cancer.
   Anticancer Res. 2025;45:2619-2628.
   PubMed         Abstract available
   
   
6. KATAOKA A, Kawasaki T, Kaira K, Hirano Y, et al
   Pathological Investigation of Grasping-related Mesenteric Injury During Laparoscopic Colorectal Cancer Resection.
   Anticancer Res. 2025;45:2493-2499.
   PubMed         Abstract available
   
   
7. ASANO Y, Han Q, Li S, Mizuta K, et al
   Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts.
   Anticancer Res. 2025;45:2257-2263.
   PubMed         Abstract available
   
   
8. KOBAYASHI Y, Takano Y, Matsukida S, Takishima T, et al
   Prognostic Nutritional Index Is the Key Prognostic Factor in Elderly Patients With Colorectal Cancer.
   Anticancer Res. 2025;45:2595-2603.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. PHAM HT, Nguyen TA, Ba TL, Tran VNM, et al
   Quality of life in patients with metastatic colorectal cancer receiving cytotoxic and cytotoxic plus targeted therapy.
   BMC Cancer. 2025;25:957.
   PubMed         Abstract available
   
   
10. JEON Y, Jung M, Jeong B, Lee H, et al
    Phase I study of the safety, tolerability, and potential therapeutic dose of OMT-110 for patients with refractory metastatic Colorectal Cancer.
    BMC Cancer. 2025;25:937.
    PubMed         Abstract available
    
    
11. SHIRZAD S, Eterafi M, Karimi Z, Barazesh M, et al
    MicroRNAs involved in colorectal cancer, a rapid mini-systematic review.
    BMC Cancer. 2025;25:934.
    PubMed         Abstract available
    
    
12. LJUNGGREN M, Dietrich CE, Rosander E, Palmer G, et al
    Correction: Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study.
    BMC Cancer. 2025;25:929.
    PubMed        
    
    
13. ZHANG X, Zhang J, Zhao C, Cai Y, et al
    Effects of individualized PEEP on pulmonary function, cerebral blood flow and postoperative cognitive function in patients undergoing laparoscopic radical resection of rectal cancer.
    BMC Cancer. 2025;25:927.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. CHEN X, Cao Y, Zhao Y, Ma Y, et al
    Neurodegeneration of local sympathetic inputs promotes colorectal cancer progression.
    Cancer Lett. 2025;625:217817.
    PubMed         Abstract available
    
    
15. SUN Y, Lu J, Tung Lau EY, Zeng Y, et al
    Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrate.
    Cancer Lett. 2025 May 23:217810. doi: 10.1016/j.canlet.2025.217810.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

16. XU N, Zhang DF, Shi XX, Yang KX, et al
    Identification and Targeting of POLQ-Associated Hereditary Colorectal Cancer.
    Clin Cancer Res. 2025 May 27. doi: 10.1158/1078-0432.CCR-25-0379.
    PubMed         Abstract available
    
    
17. DREW DA, Downie JM, Chan AT
    "PIK"ing the right patients for adjuvant aspirin therapy for colorectal cancer.
    Clin Cancer Res. 2025 May 29. doi: 10.1158/1078-0432.CCR-25-0953.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

18. BJORKLUND SAND L, Larsson C, Gronkvist R, Haglind E, et al
    Persistent Sitting and Walking Difficulties After Abdominoperineal Excision and Anterior Resection: Results From the Quality of Life in Rectal Cancer Study.
    Dis Colon Rectum. 2025;68:704-712.
    PubMed         Abstract available
    
    
19. MCMAHON RK, O'Cathail SM, Steele CW, Nair HS, et al
    Circulating Markers of Systemic Inflammation, Measured After Completion of Neoadjuvant Therapy, Associated With Response in Locally Advanced Rectal Cancer.
    Dis Colon Rectum. 2025;68:713-725.
    PubMed         Abstract available
    
    
20. CHEONG C, Kim NW, Shim SR, Kang J, et al
    Evaluating the Impact of Induction and Consolidation Total Neoadjuvant Therapies Compared to Conventional Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.
    Dis Colon Rectum. 2025;68:687-701.
    PubMed         Abstract available
    
    
21. PASCH JA, Liu WS, Kabir S, Pennington TE, et al
    Approaches to Surgical Management of Anorectal Melanoma in the Pre- and Post-Immunotherapy Eras.
    Dis Colon Rectum. 2025;68:746-752.
    PubMed         Abstract available
    
    
22. VU JV, Kanters AE, Berho M, Rivard SJ, et al
    A Multimodal Intervention to Increase Total Mesorectal Excision Grading for Rectal Cancer in Michigan: A Randomized Controlled Trial.
    Dis Colon Rectum. 2025;68:776-784.
    PubMed         Abstract available
    
    
23. KERTZMAN BAJ, Amelung FJ, Burghgraef TA, Consten ECJ, et al
    Outcomes After Elective Versus Emergency Resection for Right-Sided Colon Cancer: A Propensity Score-Matched Analysis.
    Dis Colon Rectum. 2025;68:753-763.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

24. HAFLIGER E, Nili-Asgari R, Netter J, Taieb J, et al
    Case report of two fatal cerebral hemorrhages in patients with metastatic colorectal cancer treated with Fruquintinib.
    Eur J Cancer. 2025 May 19:115517. doi: 10.1016/j.ejca.2025.115517.
    PubMed        
    
    

    
    Eur J Surg Oncol

25. MONTALTI R, Pepe F, Cassese G, Russo G, et al
    Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study.
    Eur J Surg Oncol. 2025;51:109706.
    PubMed         Abstract available
    
    
26. GOEDEGEBUURE EP, Arico FM, Lahaye MJ, Maas M, et al
    Defining the tumor location in rectal cancer - Practice variations and impact on treatment decision making.
    Eur J Surg Oncol. 2025;51:109700.
    PubMed         Abstract available
    
    
27. SU J, Liu Z, Li H, Kang L, et al
    Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer.
    Eur J Surg Oncol. 2025;51:109717.
    PubMed         Abstract available
    
    
28. BOND MJG, Verhoef C, Kazemier G, Kok NFM, et al
    Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment.
    Eur J Surg Oncol. 2025;51:109681.
    PubMed         Abstract available
    
    
29. AHMADINEJAD M, Parvizi A, Sheikhi S, Eghbal F, et al
    Optimal timing of surgery after neoadjuvant chemoradiotherapy in rectal cancer: A retrospective analysis.
    Eur J Surg Oncol. 2025;51:109702.
    PubMed         Abstract available
    
    
30. MOOLENAAR LR, van Geffen EGM, Hazen SJA, Sluckin TC, et al
    Salvageable locoregional recurrence and stoma rate after local excision of pT1-2 rectal cancer - A nationwide cross-sectional cohort study.
    Eur J Surg Oncol. 2025;51:109623.
    PubMed         Abstract available
    
    

    
    Int J Cancer

31. VAN ZUTPHEN M, Verkaar AJCF, van Duijnhoven FJB, Voortman T, et al
    Early-life anthropometry and colorectal cancer risk in adulthood: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis of prospective studies.
    Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35461.
    PubMed         Abstract available
    
    
32. STERPETTI G, Sterpetti AV
    Increased mortality from colorectal cancer in younger individuals: The preventive role of aspirin and statins.
    Int J Cancer. 2025 May 27. doi: 10.1002/ijc.35495.
    PubMed        
    
    

    
    Int J Colorectal Dis

33. WANG Y, Tan H, Li S, Long C, et al
    Dual-energy CT combined with histogram parameters in the assessment of perineural invasion in colorectal cancer.
    Int J Colorectal Dis. 2025;40:129.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

34. CHAR SK, Chan JA, Ng K
    Rising incidence of early-onset colorectal cancer: impact of anatomy and histology.
    J Natl Cancer Inst. 2025 May 29:djaf094. doi: 10.1093.
    PubMed        
    
    

    
    J Surg Oncol

35. ERKAYA M, Inal E, Benlice C, Kuzu MA, et al
    A Methodological and Survival Comparison of NCDB and SEER Database for Colon Cancer Research.
    J Surg Oncol. 2025 May 30. doi: 10.1002/jso.28141.
    PubMed         Abstract available
    
    
36. CHEN SF, Yang SH, Jiang JK, Wang LW, et al
    Outcomes of Postchemoradiotherapy Watch-and-Wait Strategy in Patients With Rectal Cancer: A 20-Year, Single-Center Study.
    J Surg Oncol. 2025;131:899-907.
    PubMed         Abstract available
    
    
37. MITSAKOS AT, Hao S, Honaker MD, Irish W, et al
    The Effect of Health Insurance on Racial Disparities in Patients With Isolated Colorectal Liver Metastases.
    J Surg Oncol. 2025;131:834-841.
    PubMed         Abstract available
    
    
38. MCGARRY JL, Quirke N, Neary C, Walsh R, et al
    Textbook Outcomes and Quality of Life Assessment Following Liver Resection for Colorectal Metastasis.
    J Surg Oncol. 2025;131:842-850.
    PubMed         Abstract available
    
    
39. KAWASHIMA J, Akabane M, Endo Y, Woldesenbet S, et al
    Recurrence Timing and Risk Following Curative Resection of Colorectal Liver Metastases: Insights From a Hazard Function Analysis.
    J Surg Oncol. 2025;131:857-864.
    PubMed         Abstract available
    
    
40. WEHRLE CJ, Tocci NX, Sun K, Jiao C, et al
    Utility of circulating tumor DNA in secondary liver malignancies: What we know and what is to come.
    J Surg Oncol. 2025;131:888-894.
    PubMed         Abstract available
    
    

    
    Oncogene

41. BAI X, Duan T, Shao J, Zhang Y, et al
    CBX3 promotes multidrug resistance by suppressing ferroptosis in colorectal carcinoma via the CUL3/NRF2/GPX2 axis.
    Oncogene. 2025;44:1678-1693.
    PubMed         Abstract available
    
    
42. PAN D, Hu J, Li G, Gao X, et al
    BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer.
    Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03453.
    PubMed         Abstract available
    
    

    
    Oncology

43. KEMNA R, Zeeuw JM, Ziesemer KA, Ali M, et al
    From development to implementation: a systematic review on the current maturity status of artificial intelligence models for patients with colorectal cancer liver metastases.
    Oncology. 2025 May 26:1-25. doi: 10.1159/000546572.
    PubMed         Abstract available
    
    
44. NUMATA K, Ono Y, Iguchi K, Uchiyama M, et al
    Prognostic significance of modified Glasgow Prognostic Score in patients undergoing FOLFOXIRI plus bevacizumab therapy for advanced or metastatic colorectal cancer.
    Oncology. 2025 May 26:1-22. doi: 10.1159/000546260.
    PubMed         Abstract available
    
    

    
    PLoS One

45. STRUSKI L, Urbanczyk T, Bucki K, Cupial B, et al
    MeVGAN: GAN-based plugin model for video generation with applications in colonoscopy.
    PLoS One. 2025;20:e0312038.
    PubMed         Abstract available
    
    
46. GROSSMANNOVA K, Belvoncikova P, Puzderova B, Simko V, et al
    Carbonic anhydrase IX downregulation linked to disruption of HIF-1, NFkappaB and STAT3 pathways as a new mechanism of ibuprofen anti-cancer effect.
    PLoS One. 2025;20:e0323635.
    PubMed         Abstract available
    
    
47. JIN'O Y, Ushikai M, Komaki Y, Masuda K, et al
    Involvement of community pharmacy pharmacists in fecal immunochemical test screening without government support in Japan.
    PLoS One. 2025;20:e0322879.
    PubMed         Abstract available
    
    
48. JEON H, Lee JL, Shim H, Joe S, et al
    Genetic variations and recurrence in stage III Korean colorectal cancer: Insights from tumor-only mutation analysis.
    PLoS One. 2025;20:e0323302.
    PubMed         Abstract available
    
    
49. RAHIMI F, Rezayatmand R, Dalvand Z, Ravankhah Z, et al
    Factors influencing participation in colorectal cancer screening among average-risk populations: A descriptive-analytical study in a developing country.
    PLoS One. 2025;20:e0323291.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.